Editorial: Bioactive sphingolipids in health and disease

Editorial: Bioactive sphingolipids in health and disease

Bibliographic Details
Main Authors:	Mutay Aslan, Yesim Oztas, Liana C. Silva
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-10-01
Series:	Frontiers in Molecular Biosciences
Subjects:	sphingolipid sphingosine glycosphingolipid ceramide ganglioside
Online Access:	https://www.frontiersin.org/articles/10.3389/fmolb.2022.1051449/full

Similar Items

Thematic Review Series: Sphingolipids. Nuclear sphingolipids: metabolism and signaling*
by: Robert W. Ledeen, et al.
Published: (2008-06-01)

A Comprehensive Review: Sphingolipid Metabolism and Implications of Disruption in Sphingolipid Homeostasis
by: Brianna M. Quinville, et al.
Published: (2021-05-01)

Chromatographic resolution and quantitative assay of CNS tissue sphingoids and sphingolipids
by: S. Dasgupta, et al.
Published: (2001-02-01)

A Review of the Role of Sphingolipids in Apoptosis Phenomenon
by: M Mashhadi Akbar Boojar, et al.
Published: (2018-12-01)

A Targeted Mass Spectrometric Analysis Reveals the Presence of a Reduced but Dynamic Sphingolipid Metabolic Pathway in an Ancient Protozoan, Giardia lamblia
by: Trevor T. Duarte, et al.
Published: (2019-07-01)

A procedure for fractionation of sphingolipid classes by solid-phase extraction on aminopropyl cartridges
by: J. Bodennec, et al.
Published: (2000-09-01)

Sphingolipids and Diagnosis, Prognosis, and Organ Damage in Systemic Lupus Erythematosus
by: Olivia C. Harden, et al.
Published: (2020-09-01)

Sphingolipids: regulators of crosstalk between apoptosis and autophagy
by: Megan M. Young, et al.
Published: (2013-01-01)

The Role of Sphingolipids in the Pathogenesis of Psoriasis
by: Mateusz Matwiejuk, et al.
Published: (2022-11-01)

Sphingolipid Metabolism and Signaling in Skeletal Muscle: From Physiology to Physiopathology
by: Sophie Tan-Chen, et al.
Published: (2020-08-01)

Targeting the Sphingolipid System as a Therapeutic Direction for Glioblastoma
by: Melinda N. Tea, et al.
Published: (2020-01-01)

Sphingolipids of Asteroidea and Holothuroidea: Structures and Biological Activities
by: Timofey V. Malyarenko, et al.
Published: (2021-06-01)

Plasma Sphingolipid Profile Associated With Subclinical Atherosclerosis and Clinical Disease Markers of Systemic Lupus Erythematosus: Potential Predictive Value
by: Samar M. Hammad, et al.
Published: (2021-07-01)

Strong Alterations in the Sphingolipid Profile of Chickens Fed a Dose of Fumonisins Considered Safe
by: Didier Tardieu, et al.
Published: (2021-10-01)

Sphingolipid Mediators of Myocardial Pathology
by: Anna Kovilakath, et al.
Published: (2020-01-01)

Antineoplastic Agents Targeting Sphingolipid Pathways
by: Alexander Kroll, et al.
Published: (2020-05-01)

Effects of sphingolipid metabolism disorders on endothelial cells
by: Yali Lai, et al.
Published: (2022-10-01)

Sphingolipids in ischemic stroke
by: Anastasia A. Rogozhina
Published: (2022-01-01)

The Role of Sphingolipids and Sphingosine-1-phosphate—Sphingosine-1-phosphate-receptor Signaling in Psoriasis
by: Kana Masuda-Kuroki, et al.
Published: (2023-09-01)

Sphingolipids: Effectors and Achilles Heals in Viral Infections?
by: Sibylle Schneider-Schaulies, et al.
Published: (2021-08-01)

Skeletal Muscle and COVID-19: The Potential Involvement of Bioactive Sphingolipids
by: Elisabetta Meacci, et al.
Published: (2022-05-01)

Sphingolipids in Atherosclerosis: Chimeras in Structure and Function
by: Lisa Peters, et al.
Published: (2022-10-01)

Sphingolipids: Important Players in Multiple Sclerosis
by: Ramona Halmer, et al.
Published: (2014-06-01)

Biosynthesis and metabolic degradation of sphingolipids not containing sialic acid
by: Pierre Morell, et al.
Published: (1972-05-01)

The Dark Side of Sphingolipids: Searching for Potential Cardiovascular Biomarkers
by: Paola Di Pietro, et al.
Published: (2023-01-01)

Sphingolipid metabolism and signaling in cardiovascular diseases
by: Sonia Borodzicz-Jażdżyk, et al.
Published: (2022-08-01)

The Anti-Infectious Role of Sphingosine in Microbial Diseases
by: Yuqing Wu, et al.
Published: (2021-05-01)

Re-Configuration of Sphingolipid Metabolism by Oncogenic Transformation
by: Anthony S. Don, et al.
Published: (2014-03-01)

Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
by: Mylene Huebecker, et al.
Published: (2019-11-01)

The function of sphingolipids in different pathogenesis of Alzheimer's disease: A comprehensive review
by: Xinyi Wang, et al.
Published: (2024-02-01)

A Brief Review of FT-IR Spectroscopy Studies of Sphingolipids in Human Cells
by: Bahar Faramarzi, et al.
Published: (2023-03-01)

Sphingolipid Levels and Signaling via Resveratrol and Antioxidant Actions in Cardiometabolic Risk and Disease
by: Melania Gaggini, et al.
Published: (2023-05-01)

Sphingolipids in Hematopoiesis: Exploring Their Role in Lineage Commitment
by: Yasharah Raza, et al.
Published: (2021-09-01)

Sphingolipid Catabolism and Glycerophospholipid Levels Are Altered in Erythrocytes and Plasma from Multiple Sclerosis Patients
by: Albena Momchilova, et al.
Published: (2022-07-01)

A Comprehensive Profiling of Cellular Sphingolipids in Mammalian Endothelial and Microglial Cells Cultured in Normal and High-Glucose Conditions
by: Koushik Mondal, et al.
Published: (2022-09-01)

Ganglioside Composition Distinguishes Anaplastic Ganglioglioma Tumor Tissue from Peritumoral Brain Tissue: Complementary Mass Spectrometry and Thin-Layer Chromatography Evidence
by: Dragana Fabris, et al.
Published: (2021-08-01)

The Role of Obesity, Inflammation and Sphingolipids in the Development of an Abdominal Aortic Aneurysm
by: Jakub Okrzeja, et al.
Published: (2022-06-01)

Splenic lipids in Gaucher's disease
by: N.G. Kennaway, et al.
Published: (1968-11-01)

Editorial: Phospholipids and sphingolipids in nutrition, metabolism, and health
by: Ronan Lordan, et al.
Published: (2023-02-01)

Resveratrol Affects Sphingolipid Metabolism in A549 Lung Adenocarcinoma Cells
by: Albena Momchilova, et al.
Published: (2022-09-01)